Cardinal Health
Executive Summary
R. P. Scherer division will manufacture Glaxo Wellcome/Vertex's AIDS protease inhibitor Agenerase (amprenavir) softgels at its newly renovated Beinheim, France facility. Amprenavir is pending at FDA with an April review deadline. Scherer made the softgel tablets for clinical trials and also manufactures Roche's protease inhibitor Fortovase (saquinavir)